| Bioactivity | GPR119 agonist 3 (Compound 21b) is an orally active agonist of GPR119 with an EC50 value of 3.8 nM for hGPR119. Additionally, GPR119 agonist 3 exhibits hypoglycemic effects and can be used in research on type 2 diabetes and obesity[1]. |
| Target | EC50: 3.8 nM (hGPR119). |
| CAS | 2097502-14-0 |
| Formula | C30H40N4O3 |
| Molar Mass | 504.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. La H, et al. Discovery of 1, 4-Disubstituted Cyclohexene Analogues as Selective GPR119 Agonists for the Treatment of Type 2 Diabetes[J]. Journal of Medicinal Chemistry, 2025. |
GPR119 agonist 3
CAS: 2097502-14-0 F: C30H40N4O3 W: 504.66
GPR119 agonist 3 (Compound 21b) is an orally active agonist of GPR119 with an EC50 value of 3.8 nM for hGPR119. Addition
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.